| Particulars |
|
|
|
| Company Name
| Alembic Pharmaceuticals Ltd
| Year End
| 202503
|
| Full Year |
| Equity (₹ Cr.) |
39.31 |
B.V. (₹) |
264.30 |
| Sales(₹ Cr.) |
6,032.63 |
NP (₹ Cr.) |
488.93 |
| NP Var% |
-27.00 |
Div% |
550.00 |
| CPS(₹) |
39.00 |
EPS (₹) |
24.90 |
| Traded Value(₹ Lakhs) |
24.83 |
52 Week High |
1,296.00 |
| 52 Week Low |
726.00 |
Price BSE |
974.00 |
| Price NSE |
975.00 |
Market Capital (₹ Cr.) |
19,141.32 |
| P/C Ratio |
25.00 |
P/E Ratio |
39.20 |
| Price Vs.BV |
3.69 |
|
| Latest Quarter |
| Year End |
202506 |
Sales (₹ Cr.) |
1,494.17 |
| NP(₹ Cr.) |
103.52 |
NP Var % |
-41.00 |
| Trailing Twelve Months |
| Year End |
202506 |
Sales |
6,118.85 |
| OPM |
19.01 |
NP |
766.41 |
| NP Var% |
-43.66 |
EPS |
21.36 |
| PE |
45.59 |
|
|